Johns Hopkins Study Exposes Orphan Drug Act Gaming - Seven of Top 10 Drugs Exploiting Tax Breaks for Rare Diseases
Johns Hopkins researchers published findings demonstrating that pharmaceutical companies were systematically gaming the 1983 Orphan Drug Act by obtaining orphan drug designations—intended for treatments of rare diseases affecting fewer than 200,000 Americans—for blockbuster drugs generating billions …
Johns Hopkins University
FDA
AbbVie
Roche
Johnson & Johnson
+4 more
pharmaceutical-industry
regulatory-capture
tax-avoidance
drug-pricing
healthcare
+2 more
Read more →